Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Acelrx Pharmaceutica (ACRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 159,092
  • Shares Outstanding, K 51,320
  • Annual Sales, $ 8,000 K
  • Annual Income, $ -51,510 K
  • 36-Month Beta 2.40
  • Price/Sales 20.54
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.80 +8.93%
on 07/12/18
4.30 -29.07%
on 06/18/18
-1.15 (-27.38%)
since 06/15/18
3-Month
2.30 +32.61%
on 05/01/18
4.30 -29.07%
on 06/18/18
+0.65 (+27.08%)
since 04/17/18
52-Week
1.55 +96.77%
on 10/19/17
5.75 -46.96%
on 10/11/17
-0.10 (-3.17%)
since 07/17/17

Most Recent Stories

More News
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) today announced the pricing of its previously announced underwritten public offering of 7,272,727 shares of its common stock, at a public offering price of $2.75...

ACRX : 3.03 (-2.26%)
AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) today announced that it has commenced an underwritten public offering of shares of its common stock. The Company expects to grant the underwriters a 30-day option...

ACRX : 3.03 (-2.26%)
Pacira (PCRX) Issues Strong Preliminary Exparel Sales for Q2

Pacira (PCRX) announces robust preliminary results for Exparel sales in second quarter on the back of increasing adoption for pain management in surgical procedures.

ACRX : 3.03 (-2.26%)
JNJ : 128.95 (+3.42%)
PCRX : 36.80 (+0.41%)
CLGN : 5.20 (-6.98%)
VIVUS' PAH Candidate Data Positive in Early Stage Study

VIVUS' (VVUS) pipeline candidate, VI-0106, shows positive activity in a preliminary analysis of phase I study in patients with pulmonary arterial hypertension.

VVUS : 0.77 (+4.59%)
ACRX : 3.03 (-2.26%)
BLRX : 0.91 (-1.09%)
CLGN : 5.20 (-6.98%)
Aclaris' Alopecia Candidate Gets Fast Track Designation

The FDA grants fast track status to Aclaris' (ACRS) JAK-inhibitor, ATI-502, for the treatment of alopecia areata.

ACRX : 3.03 (-2.26%)
ACRS : 20.11 (-1.90%)
BLRX : 0.91 (-1.09%)
CLGN : 5.20 (-6.98%)
AcelRx receives European Commission approval for DZUVEO(TM)

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx or the Company), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, today announced that the...

ACRX : 3.03 (-2.26%)
Shire (SHPG) HAE Drug Gets FDA Nod for Pediatric Population

Shire (SHPG) gains FDA approval for expanding the label of its hereditary angioedema (HAE) drug, Cinryze, to include its usage among pediatric patients aged six years and older.

ACRX : 3.03 (-2.26%)
CTLT : 43.12 (+0.61%)
SHPG : 172.67 (+0.35%)
BLRX : 0.91 (-1.09%)
Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy

Smaller drugmakers are having a relatively better year than their larger counterparts. Here are seven stocks to buy.

RDHL : 11.15 (-1.76%)
ACER : 21.70 (-3.75%)
JAZZ : 175.87 (+0.61%)
COOL : 21.74 (-5.81%)
ACRX : 3.03 (-2.26%)
ENTA : 122.99 (+1.63%)
TARO : 114.92 (+0.20%)
Top Ranked Momentum Stocks to Buy for June 15th

Top Ranked Momentum Stocks to Buy for June 15th

ACRX : 3.03 (-2.26%)
ABMD : 428.03 (+2.06%)
ABG : 68.85 (+1.55%)
Detailed Research: Economic Perspectives on Southern, AcelRx Pharmaceuticals, International Flavors & Fragrances, Pandora Media, Express Scripts Holding, and United Continental -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern Company (NYSE:SO),...

P : 8.24 (+0.12%)
UAL : 72.93 (+0.93%)
ESRX : 80.20 (-0.90%)
ACRX : 3.03 (-2.26%)
IFF : 128.62 (+0.97%)
SO : 47.62 (-0.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade ACRX with:

Business Summary

AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and...

See More

Key Turning Points

2nd Resistance Point 3.47
1st Resistance Point 3.28
Last Price 3.03
1st Support Level 2.98
2nd Support Level 2.87

See More

52-Week High 5.75
Fibonacci 61.8% 4.15
Fibonacci 50% 3.65
Fibonacci 38.2% 3.15
Last Price 3.03
52-Week Low 1.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar